Curtis Behmann

IAM Research

The Patent 1000 focuses exclusively on patent practice and has firmly established itself as the definitive 'go-to' resource for those seeking world-class legal patent expertise.

Recommended - Individuals: prosecution

Full-service firm Borden Ladner Gervais is a skilled all-rounder in the patent field, with active prosecution and litigation practices. It recently launched Beyond IP Strategy, a team of legal and business professionals across Canada who specialise in IP strategy and, using BLG’s exclusive IP strategy framework, it helps clients to develop, expand and enhance their strategy from every angle. Patrons rave about this service: “We chose BLG because of their comprehensive Beyond IP Strategy programme and I would recommend it in a heartbeat. I am blown away by the team’s diligence and knowledge, as they provide patient and thorough answers.” Leading the charge on this platform is Curtis Behmann, whose “service is outstanding, and he demonstrates a great level of commitment, professionalism and in-depth knowledge. He evaluates business needs and always find the best possible solutions.” Anchoring the group nationally, Andrew Sojonky “provides prompt, thorough and detailed advice” to companies looking to secure their patent assets – primarily in the chemical industry – as well as seamlessly managing portfolios in over 40 countries. Geoffrey de Kleine exhibits great technical agility and broad sector knowledge, but focuses his expertise on the electronics, software and telecommunications space. A variety of work has been keeping the team busy, and recently Jason Mueller-Neuhaus and Graeme Boocock have been working with Ecolab, the world leader in water, hygiene and infection prevention solutions, to maintain its entire Canadian portfolio. On behalf of Mobility View, Brandon Evenson has been developing the company’s IP strategy while also advising on commercial matters that arise, while David Nauman has been supporting ABK Biomedical with all of its prosecution needs. Looking deeper into the life sciences team, Mark Vickers, Kathleen Marsman and Jennifer Raoul are the names to note. Vickers leads the group and works closely with universities and start-ups to protect their latest inventions; Marsman makes good use of her technical qualifications to counsel her patrons and breaks down challenging problems into achievable steps; and Raoul enjoys working closely with in-house counsel of pharmaceutical and biotechnology companies, and delivering strategic guidance that is in line with their business objectives. On the contentious side of the practice, Chantal Saunders and Beverley Moore are representing Eli Lilly in several appeals regarding patent infringement, involving the tadalafil drugs Cialis and Adcirca. The pair utilise their combined experience to strike all the right notes.

Unlock unlimited access to all IAM content